Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars

PURPOSE In response to the COVID-19 pandemic, the ASCO launched a Global Webinar Series to address various aspects of cancer care during the pandemic. Here we present the lessons learned and recommendations that have emerged from these webinars. METHODS Fifteen international health care experts from different global regions and oncology disciplines participated in one of the six 1-hour webinars to discuss the latest data, share their experiences, and provide recommendations to manage cancer care during the COVID-19 pandemic. These sessions include didactic presentations followed by a moderated discussion and questions from the audience. All recommendations have been transcribed, categorized, and reviewed by the experts, who have also approved the consensus recommendations. RESULTS The summary recommendations are divided into different categories, including risk minimization; care prioritization of patients; health care team management; virtual care; management of patients with cancer undergoing surgical, radiation, and systemic therapy; clinical research; and recovery plans. The recommendations emphasize the protection of patients and health care teams from infections, delivery of timely and appropriate care, reduction of harm from the interruption of care, and preparation to handle a surge of new COVID-19 cases, complications, or comorbidities thereof. CONCLUSION The recommendations from the ASCO Global Webinar Series may guide practicing oncologists to manage their patients during the ongoing pandemic and help organizations recover from the crisis. Implementation of these recommendations may improve understanding of how COVID-19 has affected cancer care and increase readiness to manage the current and any future outbreaks effectively.

[1]  J. Warner,et al.  Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study , 2020, Cancer discovery.

[2]  C. Swanton,et al.  Cancer Research: The lessons to learn from COVID-19. , 2020, Cancer discovery.

[3]  J. Yarnold,et al.  Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Shetal I Shah,et al.  COVID-19 impact on research, lessons learned from COVID-19 research, implications for pediatric research , 2020, Pediatric Research.

[5]  V. Torri,et al.  COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study , 2020, The Lancet Oncology.

[6]  Alokkumar Jha,et al.  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study , 2020, The Lancet.

[7]  B. Ebert,et al.  The impact of the COVID-19 pandemic on cancer care , 2020, Nature Cancer.

[8]  A. Jazieh Managing Healthcare Workers During the COVID-19 Pandemic and Beyond. , 2020, Global journal on quality and safety in healthcare.

[9]  J. Warner,et al.  The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer , 2020, Cancer Cell.

[10]  E. Sawyer,et al.  Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial , 2020, The Lancet.

[11]  S. Formenti,et al.  Cancer and COVID-19 — potentially deleterious effects of delaying radiotherapy , 2020, Nature Reviews Clinical Oncology.

[12]  S. Nagesh,et al.  Saving the frontline health workforce amidst the COVID-19 crisis: Challenges and recommendations , 2020, Journal of global health.

[13]  P. Pharoah,et al.  Collateral damage: the impact on cancer outcomes of the COVID-19pandemic , 2020, medRxiv.

[14]  S. Fröhling,et al.  Caring for patients with cancer in the COVID-19 era , 2020, Nature Medicine.

[15]  Andrew K. Przybylski,et al.  Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science , 2020, The Lancet Psychiatry.

[16]  COVIDSurg Collaborative Global guidance for surgical care during the COVID-19 pandemic , 2020, The British journal of surgery.

[17]  E. Tapper,et al.  The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care , 2020, Journal of Hepatology.

[18]  E. Basch,et al.  Oncology Practice During the COVID-19 Pandemic. , 2020, JAMA.

[19]  Yan Guo,et al.  Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind , 2020, Infectious Diseases of Poverty.

[20]  T. Shanafelt,et al.  Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic. , 2020, JAMA.

[21]  G. Curigliano,et al.  A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group , 2020, The oncologist.

[22]  Prabhas V. Moghe,et al.  The COVID-19 pandemic and research shutdown: staying safe and productive. , 2020, The Journal of clinical investigation.

[23]  T. Burki Cancer guidelines during the COVID-19 pandemic , 2020, The Lancet Oncology.

[24]  C. Booth,et al.  Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic , 2020, Nature Reviews Clinical Oncology.

[25]  R. Fisher,et al.  A War on Two Fronts: Cancer Care in the Time of COVID-19 , 2020, Annals of Internal Medicine.

[26]  M. Knoll,et al.  The Impact of COVID-19 on Radiation Oncology Clinics and Patients With Cancer in the United States , 2020, Advances in Radiation Oncology.

[27]  A. Ravaud,et al.  The official French guidelines to protect patients with cancer against SARS-CoV-2 infection , 2020, The Lancet Oncology.

[28]  John P. A. Ioannidis,et al.  Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures , 2020, European journal of clinical investigation.

[29]  R. Walls,et al.  Supporting the Health Care Workforce During the COVID-19 Global Epidemic. , 2020, JAMA.

[30]  J. Hollander,et al.  Virtually Perfect? Telemedicine for Covid-19. , 2020, The New England journal of medicine.

[31]  A. Jazieh,et al.  Managing Oncology Services During a Major Coronavirus Outbreak: Lessons From the Saudi Arabia Experience , 2020, JCO global oncology.

[32]  Min Chen,et al.  The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus , 2020, The Lancet Psychiatry.

[33]  Ana Maria Lopez,et al.  Telemedicine in Cancer Care. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[34]  E. Susser,et al.  The Psychological Impact of the SARS Epidemic on Hospital Employees in China: Exposure, Risk Perception, and Altruistic Acceptance of Risk , 2009, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[35]  C. Tournigand,et al.  OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.